Table 4

Annual prevalence of diabetic nephropathy in pediatric patients with diabetes for all cases stratified by age and sex and for probable cases only: U.S. MarketScan data, 2002–2003

YearAll casesProbable cases only
Age (years)*Sex
<22 to < 66 to <1212 to <18MaleFemale
2002n/a0.31 (0–1.72)0.20 (0.04–0.60)1.62 (1.23–2.08)0.95 (0.62–1.39)1.36 (0.96–1.87)0.83 (0.61–1.11)
2003n/a0.18 (0–0.98)0.40 (0.19–0.74)2.21 (1.86–2.61)1.26 (0.96–1.63)1.94 (1.56–2.37)1.24 (1.03–1.49)
2004n/a0.39 (0.08–1.13)0.68 (0.43–1.02)2.52 (2.19–2.88)1.66 (1.36–2.01)2.13 (1.79–2.52)1.46 (1.26–1.68)
2005n/a0.55 (0.15–1.40)0.81 (0.55–1.16)3.14 (2.79–3.52)2.18 (1.85–2.56)2.57 (2.21–2.97)1.75 (1.53–1.98)
2006n/a0.33 (0.04–1.19)0.89 (0.59–1.28)3.29 (2.91–3.70)2.27 (1.91–2.67)2.74 (2.35–3.19)1.97 (1.73–2.23)
20072.44 (0.03–13.57)0.35 (0.07–1.02)0.89 (0.65–1.18)3.15 (2.86–3.46)2.24 (1.96–2.56)2.61 (2.30–2.95)1.91 (1.73–2.12)
20085.26 (1.06–15.38)0.72 (0.29–1.49)1.21 (0.95–1.51)3.56 (3.28–3.86)2.62 (2.34–2.92)3.03 (2.73–3.36)2.19 (2.00–2.38)
2009n/a0.79 (0.36–1.50)1.46 (1.20–1.76)3.70 (3.44–3.98)2.73 (2.46–3.02)3.25 (2.96–3.56)2.24 (2.07–2.42)
20101.59 (0.02–8.83)1.08 (0.59–1.82)1.53 (1.28–1.82)3.63 (3.39–3.89)2.63 (2.39–2.89)3.34 (3.06–3.63)2.18 (2.02–2.35)
2011n/a0.70 (0.34–1.29)1.51 (1.27–1.78)3.73 (3.49–3.97)2.78 (2.55–3.03)3.30 (3.04–3.57)2.17 (2.02–2.32)
2012n/a0.22 (0.04–0.64)1.59 (1.34–1.87)3.94 (3.71–4.19)2.92 (2.68–3.17)3.55 (3.28–3.83)2.24 (2.09–2.40)
2013n/a0.44 (0.14–1.03)1.29 (1.04–1.58)4.30 (4.03–4.58)3.04 (2.77–3.32)3.86 (3.55–4.19)2.32 (2.16–2.50)
  • Data are prevalence of diabetic nephropathy per 100 pediatric patients with diabetes (95% CI). n/a, not applicable because of zero cases.

  • *P values <0.05 for years 2002 through 2013, χ2 test.

  • P values <0.05 for years 2009 through 2013, χ2 test.